Baxter and adventhealth tampa announce cost savings achieved through intraoperative hemostasis management program

Tampa, fla.--(business wire)--baxter international inc. (nyse:bax), a global leader in advancing surgical innovation, and adventhealth tampa today announced that adventhealth tampa will realize approximately $200,000 in annual savings through its involvement in baxter's vital edge program. vital edge is a data-driven, evidence-based intraoperative hemostasis management program designed to help hospitals and health care providers improve hemostasis utilization practices impacting three interconn
BAX Ratings Summary
BAX Quant Ranking